Novel strategies to improve the endocrine therapy of breast cancer

Endocrine therapy (ET) constitutes the usual first-line of therapy for patients in the treatment of metastatic hormone receptorpositive breast cancer. Unfortunately, not all patients respond to first-line endocrine treatment due to intrinsic resistance, while others may initially respond but eventua...

Full description

Bibliographic Details
Main Author: Aurelio Bartolome Castrellon
Format: Article
Language:English
Published: PAGEPress Publications 2017-05-01
Series:Oncology Reviews
Subjects:
Online Access:http://www.oncologyreviews.org/index.php/or/article/view/323